A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy
NOT ENROLLING
Trial ID:
NCT03767244 Protocol # :
19-140
Phase
III
Disease Sites
Prostate
Principal Investigator
Taplin, Mary-Ellen
Site Investigator
Bubley, Glenn
Site Research Nurses
Aspinwall, Sheridan
Aspinwall, Sheridan
Bretta, Katherine, v.
Carey, Margaret, M.
Creaton, Eileen
Gundy, Kathryn, E.
Kabarame, Liliane
Kelleher, Kaitlin
Lagerstedt, Elizabeth
Leisner, Claire
Mingrino, Sage
Morse, Linda, K.
Pace, Amanda
Polinski, Karen
Porter, Kathryn
Prisby, Judith
Theodore, Catherine
Walsh, Meghara
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #19-140
19-140